Innovation, alliances, and networks in high-tech environments / edited by Fiorenza Belussi, Luigi Orsi.
Saved in:
| Online Access: |
Full Text (via Taylor & Francis) |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
London :
Routledge,
2015.
|
| Series: | Studies in global competition.
|
| Subjects: |
Table of Contents:
- ""Innovation, Alliances, and Networks in High-Tech Environments""; ""Series Page""; ""Title""; ""Copyright""; ""Contents""; ""List of Figures""; ""List of Tables""; ""List of Contributors""; ""Introduction""; ""PART I Alliances and Networks""; ""1 The Emergence of the Red Biotech Niche and Its Evanescent Dissolution into the Integrated Parallel ‘Knowledge System’ of a New Biopharmaceutical FiliÃr̈e: An Evolutionary Perspective""; ""Introduction""; ""Disruptive Technologies and the Emergence of New Niches""; ""Partner Alliances Supporting the Emergence of the Bioniche""
- ""The Organizational Reactions of Incumbents to Potential Threats Represented by the Emergence of Red Bioniche was the Activation of a Flow of M & A""""Conclusions""; ""Acknowledgements""; ""Notes""; ""References""; ""2 Innovation in US Metropolitan Areas: The Role of Global Connectivity""; ""Introduction""; ""Data and Methods""; ""Preliminary Findings""; ""Conclusion""; ""Note""; ""References""; ""3 Competition and Cooperation in Entrepreneurial Ecosystems: A Lifecycle Analysis of a Canadian ICT Ecosystem""; ""Introduction""; ""Theoretical Background""; ""Methods""; ""Analysis of the Case""
- ""Contribution and Conclusion""""References""; ""PART II Alliances and Innovation""; ""4 Partnering Strategies in Biotech Firms: A Longitudinal Perspective""; ""Introduction""; ""Theory and Hypotheses""; ""Methods""; ""Results""; ""Discussion and Conclusions""; ""Notes""; ""References""; ""5 Management of the Collaboration Network of Italian Biotech Firms: Do Firms Experience a Diminishing Return from Alliances?""; ""Introduction""; ""The Management of Strategic Alliances""; ""Methodology""; ""Results""; ""Discussion and Conclusions""; ""References""
- ""6 Which Alliance Partners become Attractive Targets for Acquisitions in Biotech? Prior Experience Versus Relational Capabilities""""Introduction""; ""Theory and Hypotheses""; ""Empirical Analysis""; ""Results""; ""Discussion and Conclusion""; ""Limitations and Future Research""; ""Notes""; ""References""; ""7 Do Acquisitions Increase Acquirers’ Innovative Performance in the Biopharma industry? An Empirical Investigation""; ""Introduction""; ""Research on Acquisitions""; ""Quantitative and Qualitative Indicators of Innovativeness""; ""Methodology""; ""Results and Discussion""
- ""Conclusions""""Note""; ""References""; ""8 Post-M & A Absorption-Related Invention Capacity in the Biopharmaceutical Industry""; ""Introduction""; ""The Role of Technological Relatedness in Absorption-Related Invention Process""; ""The Effect of Alliance and M & A Experience in Capturing the Knowledge Produced by the Partner Firm""; ""Methodology""; ""Results""; ""Discussion""; ""Conclusion""; ""Note""; ""References""; ""9 Are M & As Driving Exploitation or Exploration?""; ""Introduction""; ""Theoretical Background and Hypotheses Building""; ""Methods""; ""Results""; ""Discussion""